166 related articles for article (PubMed ID: 7686443)
1. Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.
Zagars GK; von Eschenbach AC
Cancer; 1993 Jul; 72(2):538-48. PubMed ID: 7686443
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
Zagars GK
J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy.
Zagars GK
Int J Radiat Oncol Biol Phys; 1992; 23(1):47-53. PubMed ID: 1374065
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
Zagars GK; Pollack A; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.
Zagars GK; Pollack A; Kavadi VS; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):293-306. PubMed ID: 7538498
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era.
Zagars GK; Pollack A; von Eschenbach AC
Cancer; 1997 Apr; 79(7):1370-80. PubMed ID: 9083160
[TBL] [Abstract][Full Text] [Related]
7. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications.
Kavadi VS; Zagars GK; Pollack A
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):279-87. PubMed ID: 7523340
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate.
Zagars GK
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):39-45. PubMed ID: 7690017
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer.
Zagars GK; Pollack A
Radiother Oncol; 1997 Sep; 44(3):213-21. PubMed ID: 9380819
[TBL] [Abstract][Full Text] [Related]
10. The results of radical prostatectomy at a community hospital during the prostate specific antigen era.
Smitt MC; Heltzel M
Cancer; 1996 Mar; 77(5):928-33. PubMed ID: 8608486
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of PSA levels in radiation therapy of patients with carcinoma of the prostate: the UCLA experience 1988-1992.
Schneider SB; Schweitzer VG; Parker RG; Bycott PW
Am J Clin Oncol; 1996 Feb; 19(1):65-72. PubMed ID: 8554039
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer.
Pollack A; Zagars GK; Kavadi VS
Cancer; 1994 Jul; 74(2):670-8. PubMed ID: 7518341
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen and external beam radiation therapy in prostate cancer.
Zagars GK; Sherman NE; Babaian RJ
Cancer; 1991 Jan; 67(2):412-20. PubMed ID: 1702349
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.
Zagars GK; Pollack A
Urology; 1995 Mar; 45(3):476-83. PubMed ID: 7533459
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.
Chauvet B; Félix-Faure C; Lupsascka N; Fijuth J; Brewer Y; Davin JL; Kirscher S; Reboul F
J Clin Oncol; 1994 Jul; 12(7):1402-7. PubMed ID: 7517443
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
17. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.
Lee WR; Hanks GE; Schultheiss TE; Corn BW; Hunt MA
J Clin Oncol; 1995 Feb; 13(2):464-9. PubMed ID: 7531222
[TBL] [Abstract][Full Text] [Related]
18. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.
Zietman AL; Coen JJ; Shipley WU; Willett CG; Efird JT
J Urol; 1994 Mar; 151(3):640-5. PubMed ID: 7508522
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer.
Ritter MA; Messing EM; Shanahan TG; Potts S; Chappell RJ; Kinsella TJ
J Clin Oncol; 1992 Aug; 10(8):1208-17. PubMed ID: 1378886
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer.
Kuban DA; el-Mahdi AM; Schellhammer PF
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):307-16. PubMed ID: 7538499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
